Total Payments
$5,199
2024 Payments
$4,183
Companies
36
Transactions
107
Medicare Patients
161
Medicare Billing
$17,306
Payment Breakdown by Category
Food & Beverage$3,304 (63.6%)
Consulting$1,775 (34.1%)
Education$119.95 (2.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,304 | 103 | 63.6% |
| Consulting Fee | $1,775 | 2 | 34.1% |
| Education | $119.95 | 2 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| TAIHO ONCOLOGY, INC. | $1,120 | 2 | $0 (2024) |
| BeiGene USA, Inc. | $762.53 | 6 | $0 (2024) |
| GENZYME CORPORATION | $268.63 | 6 | $0 (2024) |
| Merck Sharp & Dohme LLC | $240.70 | 8 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $185.34 | 9 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $174.64 | 3 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $167.74 | 3 | $0 (2024) |
| Astellas Pharma US Inc | $160.20 | 3 | $0 (2024) |
| Genmab U.S., Inc. | $159.72 | 3 | $0 (2024) |
| MorphoSys, US Inc. | $139.98 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,183 | 92 | TAIHO ONCOLOGY, INC. ($1,120) |
| 2023 | $537.69 | 10 | MorphoSys, US Inc. ($139.98) |
| 2022 | $245.64 | 3 | E.R. Squibb & Sons, L.L.C. ($120.09) |
| 2021 | $233.34 | 2 | Alexion Pharmaceuticals, Inc. ($120.04) |
All Payment Transactions
107 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Incyte Corporation | MONJUVI (Drug), PEMAZYRE | Food and Beverage | Cash or cash equivalent | $25.93 | General |
| Category: Oncology | ||||||
| 12/17/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Education | In-kind items and services | $20.00 | General |
| Category: Oncology | ||||||
| 12/10/2024 | BeiGene USA, Inc. | BRUKINSA (Drug), TEVIMBRA | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: Oncology | ||||||
| 12/09/2024 | Astellas Pharma US Inc | Vyloy (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Oncology | ||||||
| 12/05/2024 | JAZZ PHARMACEUTICALS INC. | ZIIHERA (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/04/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $21.05 | General |
| Category: Hematology | ||||||
| 12/03/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $33.09 | General |
| Category: ONCOLOGY | ||||||
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Oncology | ||||||
| 11/26/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Consulting Fee | Cash or cash equivalent | $675.00 | General |
| Category: Oncology | ||||||
| 11/25/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: Oncology | ||||||
| 11/22/2024 | Agios Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $14.99 | General |
| 11/20/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $28.12 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $36.21 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $29.54 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Oncology | ||||||
| 11/06/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug), Odomzo | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $33.14 | General |
| Category: ONCOLOGY | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $28.26 | General |
| Category: Oncology | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Oncology | ||||||
| 10/22/2024 | ARRAY BIOPHARMA INC | XALKORI (Drug), INLYTA, LORBRENA | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: Oncology | ||||||
| 10/20/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $113.97 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 161 | 11,444 | $44,268 | $17,306 |
Total Patients
161
Total Services
11,444
Medicare Billing
$17,306
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2023 | 13 | 11,250 | $22,500 | $9,905 | 44.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 21 | $4,179 | $1,974 | 47.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 17 | 19 | $7,125 | $1,747 | 24.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $3,626 | $1,713 | 47.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 18 | 20 | $3,700 | $911.20 | 24.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 23 | 37 | $555.00 | $303.27 | 54.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 25 | $1,675 | $259.00 | 15.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 19 | 34 | $476.00 | $253.82 | 53.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 18 | 24 | $432.00 | $240.37 | 55.6% |
About Brian Schlick
Brian Schlick is a Hematology & Oncology healthcare provider based in Tullahoma, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2017. The National Provider Identifier (NPI) number assigned to this provider is 1063946945.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brian Schlick has received a total of $5,199 in payments from pharmaceutical and medical device companies, with $4,183 received in 2024. These payments were reported across 107 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($3,304).
As a Medicare-enrolled provider, Schlick has provided services to 161 Medicare beneficiaries, totaling 11,444 services with total Medicare billing of $17,306. Data is available for 1 year (2023–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Tullahoma, TN
- Active Since 04/17/2017
- Last Updated 09/27/2023
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1063946945
Products in Payments
- INQOVI (Drug) $1,100
- BRUKINSA (Drug) $762.53
- KEYTRUDA (Biological) $206.42
- LIBTAYO (Biological) $196.67
- MONJUVI (Drug) $165.91
- ZEPZELCA (Drug) $161.77
- Epkinly (Drug) $159.72
- SARCLISA (Biological) $155.33
- Pomalyst (Drug) $144.45
- Ultomiris (Drug) $120.04
- Lenvima (Drug) $119.17
- clonoSEQ (Device) $117.94
- ARCPOINT (Device) $105.41
- FOTIVDA (Drug) $90.13
- BRAFTOVI (Drug) $84.24
- Enhertu (Drug) $83.52
- REBLOZYL (Biological) $81.25
- Trodelvy (Drug) $80.40
- PLUVICTO (Drug) $57.32
- ULTOMIRIS (Biological) $54.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.